Targeting Inflammation to Reduce CVD Risk: a Realistic Clinical Prospect? (Joint Symposium of the British Pharmacological Society (BPS) and the Italian Society of Pharmacology (SIF) with the contribute of the Federation of European Pharmacological Societies (EPHAR))
